NanoPacific Holdings Inc is a privately held research and development company commercializing and developing various precision-targeted, controlled delivery applications and products. NanoPacific Holdings research focuses on the fields of synthetic co-polypeptides, nanoemulsions and silica nanoparticles for the Biomedical, Cosmetics, Bio-industrial, Environmental and Food and Agricultural markets. Synthetic polypeptides can be designed and developed well-defined initiators to polymerize amino acid derivatives. By adding a chemical reaction, amino acids are added to a growing polypeptide chain in batches creating series of transition-metal complexes which could perform controlled polymerizations, yielding high molecular weight polypeptides. Synthetic Co-polypeptides could have uses in anti-microbial, surfactants or emulsifiers, hydrogels/scaffolding and drug delivery/depots fields. Nanoemulsions are dispersions of nanodroplets made by processes of flow-induced droplet rupturing. NPH's nanoemulsion technologies can be used to improve the texture and feel of emulsion products with minimal reformulation. In many cases, reduced oil and surfactant content can be achieved in oil-in-water emulsion formulations while controlling and maintaining a desired texture and feel. Uses of nanoemulsionsâ¨include anti-microbials, drug delivery, industrial hygiene, texture/viscosity modifiers, low-fat foods, taste masking and vaccine adjuvants. NPH partner scientists created molecular valves and rotors to enable the release of loaded compounds by a variety of specific stimuli, ranging from pH to electromagnetic energy. There are substantial commercial opportunities for these controlled-release silica nanoparticles. Notably, they have potential for fine-tuned drug delivery, with greater control over the quantity and location of release.
